Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Ulrich

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
Neuropharmacology|December 12, 2022
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's diseaseDeidiane Elisa Ribeiro, Lyvia Lintzmaier Petiz, Talita Glaser, et al.
Stem Cell Reviews and Reports|March 24, 2022
Effects of Magnetite Nanoparticles and Static Magnetic Field on Neural Differentiation of Pluripotent Stem CellsAna T Semeano, Fabiano A Tofoli, Juliana C Corrêa-Velloso, et al.
Molecular Biology Reports|February 6, 2019
Antiproliferative and apoptotic effects of caffeic acid on SK-Mel-28 human melanoma cancer cellsLuana Paula Pelinson, Charles Elias Assmann, Taís Vidal Palma, et al.
ACS Omega|September 7, 2022
Molecular Dynamics Analysis of Fast-Spreading Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Their Effects on the Interaction with Human Angiotensin-Converting Enzyme 2Anacleto Silva de Souza, Vitor Martins de Freitas Amorim, Gabriela D A Guardia, et al.
Neuropharmacology|January 7, 2020
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autismMauro Mozael Hirsch, Iohanna Deckmann, Júlio Santos-Terra, et al.
Pharmaceutics|January 21, 2022
Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of GlioblastomaRavena Pereira do Nascimento, Balbino Lino Dos Santos, Jéssika Alves Oliveira Amparo, et al.
Frontiers in Immunology|October 17, 2022
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patientsAnna Julia Pietrobon, Roberta Andrejew, Ricardo Wesley Alberca Custódio, et al.
Brain, Behavior, & Immunity - Health|October 27, 2025
Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? Insights from a Brazilian cohortEthiane Segabinazi, Fernando R Tocantins, Talita Glaser, et al.
Seminars in Cell & Developmental Biology|October 1, 2022
Organoids as a novel tool in modelling infectious diseasesLucas Felipe de Oliveira, Daniel Mendes Filho, Bruno Lemes Marques, et al.
Cell Death & Disease|April 20, 2026
Methodological guidelines for P2X receptor assays and data interpretationDariusz C Gorecki, Elena Adinolfi, Sahil Adriouch, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
Neuropharmacology|December 12, 2022
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's diseaseDeidiane Elisa Ribeiro, Lyvia Lintzmaier Petiz, Talita Glaser, et al.
Stem Cell Reviews and Reports|March 24, 2022
Effects of Magnetite Nanoparticles and Static Magnetic Field on Neural Differentiation of Pluripotent Stem CellsAna T Semeano, Fabiano A Tofoli, Juliana C Corrêa-Velloso, et al.
Molecular Biology Reports|February 6, 2019
Antiproliferative and apoptotic effects of caffeic acid on SK-Mel-28 human melanoma cancer cellsLuana Paula Pelinson, Charles Elias Assmann, Taís Vidal Palma, et al.
ACS Omega|September 7, 2022
Molecular Dynamics Analysis of Fast-Spreading Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Their Effects on the Interaction with Human Angiotensin-Converting Enzyme 2Anacleto Silva de Souza, Vitor Martins de Freitas Amorim, Gabriela D A Guardia, et al.
Neuropharmacology|January 7, 2020
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autismMauro Mozael Hirsch, Iohanna Deckmann, Júlio Santos-Terra, et al.
Pharmaceutics|January 21, 2022
Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of GlioblastomaRavena Pereira do Nascimento, Balbino Lino Dos Santos, Jéssika Alves Oliveira Amparo, et al.
Frontiers in Immunology|October 17, 2022
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patientsAnna Julia Pietrobon, Roberta Andrejew, Ricardo Wesley Alberca Custódio, et al.
Brain, Behavior, & Immunity - Health|October 27, 2025
Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? Insights from a Brazilian cohortEthiane Segabinazi, Fernando R Tocantins, Talita Glaser, et al.
Seminars in Cell & Developmental Biology|October 1, 2022
Organoids as a novel tool in modelling infectious diseasesLucas Felipe de Oliveira, Daniel Mendes Filho, Bruno Lemes Marques, et al.
Cell Death & Disease|April 20, 2026
Methodological guidelines for P2X receptor assays and data interpretationDariusz C Gorecki, Elena Adinolfi, Sahil Adriouch, et al.
Pageof 27